Full Text of HB0118 95th General Assembly
HB0118sam001 95TH GENERAL ASSEMBLY
|
Sen. John M. Sullivan
Filed: 5/8/2007
|
|
09500HB0118sam001 |
|
LRB095 03934 RAS 35945 a |
|
| 1 |
| AMENDMENT TO HOUSE BILL 118
| 2 |
| AMENDMENT NO. ______. Amend House Bill 118 by replacing | 3 |
| everything after the enacting clause with the following:
| 4 |
| "Section 5. The Illinois Dental Practice Act is amended by | 5 |
| adding Section 11.5 as follows: | 6 |
| (225 ILCS 25/11.5 new) | 7 |
| Sec. 11.5. Underserved population dental license pilot | 8 |
| program. | 9 |
| (a) The Department shall create an underserved population | 10 |
| dental license pilot program under which it shall issue | 11 |
| underserved population dental licenses to persons who are | 12 |
| graduates of a dental education program in a country other than | 13 |
| the United States or its territories or Canada and who hold a | 14 |
| current, valid license or authorization to practice dentistry | 15 |
| in a country other than the United States or its territories or | 16 |
| Canada. |
|
|
|
09500HB0118sam001 |
- 2 - |
LRB095 03934 RAS 35945 a |
|
| 1 |
| (b) Persons holding underserved population dental licenses | 2 |
| may practice only in federally-designated dental health | 3 |
| professional shortage areas located in this State and must meet | 4 |
| each of the following qualifications: | 5 |
| (1) He or she must be a United States citizen or a | 6 |
| lawfully-admitted alien. | 7 |
| (2) He or she must be at least 21 years of age and of | 8 |
| good moral character. | 9 |
| (3) He or she must pass an examination authorized or | 10 |
| given by the Department in the theory and practice of the | 11 |
| science of dentistry, provided that the Department (i) may | 12 |
| recognize a certificate granted by the National Board of | 13 |
| Dental Examiners in lieu of or subject to such examination, | 14 |
| as may be required and (ii) may recognize the successful | 15 |
| completion of the clinical examination conducted by | 16 |
| approved regional testing services in lieu of such | 17 |
| examinations, as may be required. For the purposes of this | 18 |
| item (3), "successful completion" means that the applicant | 19 |
| has achieved a minimum passing score on the regional | 20 |
| examinations, as determined by each approved regional | 21 |
| testing service. | 22 |
| (4) He or she must present satisfactory evidence of the | 23 |
| completion of dental education by graduation from a dental | 24 |
| college or school outside of the United States or Canada | 25 |
| and provide satisfactory evidence that he or she has | 26 |
| achieved the same level of scientific knowledge and |
|
|
|
09500HB0118sam001 |
- 3 - |
LRB095 03934 RAS 35945 a |
|
| 1 |
| clinical competence as required of all graduates of the | 2 |
| college, school, or advanced dental education program. | 3 |
| (c) In determining an applicant's professional capacity | 4 |
| for licensure under the pilot program, an individual who (i) | 5 |
| has not been actively engaged in the practice of dentistry, | 6 |
| (ii) has not been a dental student, or (iii) has not been | 7 |
| engaged in a formal program of dental education during the 5 | 8 |
| years immediately preceding the filing of an application may be | 9 |
| required to complete such additional testing, training, or | 10 |
| remedial education as the Board may deem necessary to establish | 11 |
| the applicant's present capacity to practice dentistry with | 12 |
| reasonable judgment, skill, and safety.
| 13 |
| (d) All candidates for licensure under the pilot program | 14 |
| must be certified by the Department. The Department may | 15 |
| contract with outside consultants or a national professional | 16 |
| organization to survey and evaluate candidates. Such | 17 |
| consultant or organization shall report to the Department | 18 |
| regarding its findings. | 19 |
| (e) An applicant for licensure under the pilot program who | 20 |
| has graduated from a dental education program outside of the | 21 |
| United States or Canada or its territories and whose first | 22 |
| language is not English must submit certification of passage of | 23 |
| the Test of English as a Foreign Language (TOEFL), as defined | 24 |
| by rule. The Department may, upon recommendation of the | 25 |
| certifying body, waive the requirement that the applicant pass | 26 |
| the TOEFL examination if the applicant submits verification of |
|
|
|
09500HB0118sam001 |
- 4 - |
LRB095 03934 RAS 35945 a |
|
| 1 |
| the successful completion of a dental education program | 2 |
| conducted in English. | 3 |
| (f) Underserved population dental licensees must agree to | 4 |
| provide all allowable services under the dental programs | 5 |
| administered by the Department of Healthcare and Family | 6 |
| Services, including the Medicaid Program and the Covering ALL | 7 |
| KIDS Health Insurance Program. These allowable services | 8 |
| include without limitation preventative treatments, | 9 |
| endodontics, and crown and bridge work. An underserved | 10 |
| population dental licensee may not refuse to treat a patient | 11 |
| eligible under dental programs administered by the Department | 12 |
| of Healthcare and Family Services. | 13 |
| (g) An underserved population dental license shall be | 14 |
| automatically revoked if the licensee ceases to practice in the | 15 |
| federally-designated dental health professional shortage area. | 16 |
| An applicant must commit to practice under an underserved | 17 |
| population dental license for a period of 5 years. No more than | 18 |
| 50 underserved population dental licenses may be active at one | 19 |
| time. | 20 |
| (h) An underserved population dental licensee must be | 21 |
| supervised by a supervising dentist. The supervising dentist | 22 |
| shall be the primary dentist who, within his or her expertise, | 23 |
| may delegate a variety of tasks and procedures and may delegate | 24 |
| prescriptive authority to the underserved dental population | 25 |
| licensee. These tasks and procedures must be delegated within | 26 |
| established guidelines and the supervising dentist shall |
|
|
|
09500HB0118sam001 |
- 5 - |
LRB095 03934 RAS 35945 a |
|
| 1 |
| maintain the final responsibility for the care of all patients | 2 |
| and the performance of the underserved population dental | 3 |
| licensee. Underserved population dental licensees may be | 4 |
| supervised only by dentists, as defined in this Act, who are | 5 |
| engaged in clinical practice or in clinical practice in public | 6 |
| health or other community health facilities. Each supervising | 7 |
| dentist shall file a notice of supervision of an underserved | 8 |
| population dental licensee, as established by rule. | 9 |
| An underserved population dental licensee may be employed | 10 |
| by a practice group or other entity employing multiple dentists | 11 |
| at one or more locations. In that case, one of the dentists | 12 |
| practicing at a location shall be designated the supervising | 13 |
| dentist. The other dentists with that practice group or other | 14 |
| entity who practice in the same general type of practice or | 15 |
| specialty as the supervising dentist may supervise the | 16 |
| underserved population dental licensees with respect to their | 17 |
| patients without being deemed alternate supervising dentists | 18 |
| for the purposes of this Section. | 19 |
| Nothing in this Section shall be construed to limit the | 20 |
| delegation of tasks or duties by a dentist to an underserved | 21 |
| dental population licensee or other appropriately trained | 22 |
| personnel. | 23 |
| Nothing in this Section shall be construed to prohibit the | 24 |
| employment of underserved population dental licensees by a | 25 |
| health care facility where such licensees function under the | 26 |
| supervision of a supervising dentist.
Duties of each |
|
|
|
09500HB0118sam001 |
- 6 - |
LRB095 03934 RAS 35945 a |
|
| 1 |
| underserved population dental licensee are limited to those | 2 |
| within the scope of practice of the supervising dentist who is | 3 |
| fully responsible for all underserved dental population | 4 |
| licensee activities. | 5 |
| (i) Beginning 5 years after the effective date of this | 6 |
| amendatory Act of the 95th General Assembly, no new licenses | 7 |
| may be issued under the pilot program.
| 8 |
| (j) The Department shall adopt all rules necessary for the | 9 |
| administration of this Section.
| 10 |
| Section 10. The Illinois Controlled Substances Act is | 11 |
| amended by changing Section 102 as follows: | 12 |
| (720 ILCS 570/102) (from Ch. 56 1/2, par. 1102) | 13 |
| Sec. 102. Definitions. As used in this Act, unless the | 14 |
| context
otherwise requires:
| 15 |
| (a) "Addict" means any person who habitually uses any drug, | 16 |
| chemical,
substance or dangerous drug other than alcohol so as | 17 |
| to endanger the public
morals, health, safety or welfare or who | 18 |
| is so far addicted to the use of a
dangerous drug or controlled | 19 |
| substance other than alcohol as to have lost
the power of self | 20 |
| control with reference to his addiction.
| 21 |
| (b) "Administer" means the direct application of a | 22 |
| controlled
substance, whether by injection, inhalation, | 23 |
| ingestion, or any other
means, to the body of a patient, | 24 |
| research subject, or animal (as
defined by the Humane |
|
|
|
09500HB0118sam001 |
- 7 - |
LRB095 03934 RAS 35945 a |
|
| 1 |
| Euthanasia in Animal Shelters Act) by:
| 2 |
| (1) a practitioner (or, in his presence, by his | 3 |
| authorized agent),
| 4 |
| (2) the patient or research subject at the lawful | 5 |
| direction of the
practitioner, or
| 6 |
| (3) a euthanasia technician as defined by the Humane | 7 |
| Euthanasia in
Animal Shelters Act.
| 8 |
| (c) "Agent" means an authorized person who acts on behalf | 9 |
| of or at
the direction of a manufacturer, distributor, or | 10 |
| dispenser. It does not
include a common or contract carrier, | 11 |
| public warehouseman or employee of
the carrier or warehouseman.
| 12 |
| (c-1) "Anabolic Steroids" means any drug or hormonal | 13 |
| substance,
chemically and pharmacologically related to | 14 |
| testosterone (other than
estrogens, progestins, and | 15 |
| corticosteroids) that promotes muscle growth,
and includes:
| 16 |
| (i) boldenone,
| 17 |
| (ii) chlorotestosterone,
| 18 |
| (iii) chostebol,
| 19 |
| (iv) dehydrochlormethyltestosterone,
| 20 |
| (v) dihydrotestosterone,
| 21 |
| (vi) drostanolone,
| 22 |
| (vii) ethylestrenol,
| 23 |
| (viii) fluoxymesterone,
| 24 |
| (ix) formebulone,
| 25 |
| (x) mesterolone,
| 26 |
| (xi) methandienone,
|
|
|
|
09500HB0118sam001 |
- 8 - |
LRB095 03934 RAS 35945 a |
|
| 1 |
| (xii) methandranone,
| 2 |
| (xiii) methandriol,
| 3 |
| (xiv) methandrostenolone,
| 4 |
| (xv) methenolone,
| 5 |
| (xvi) methyltestosterone,
| 6 |
| (xvii) mibolerone,
| 7 |
| (xviii) nandrolone,
| 8 |
| (xix) norethandrolone,
| 9 |
| (xx) oxandrolone,
| 10 |
| (xxi) oxymesterone,
| 11 |
| (xxii) oxymetholone,
| 12 |
| (xxiii) stanolone,
| 13 |
| (xxiv) stanozolol,
| 14 |
| (xxv) testolactone,
| 15 |
| (xxvi) testosterone,
| 16 |
| (xxvii) trenbolone, and
| 17 |
| (xxviii) any salt, ester, or isomer of a drug or | 18 |
| substance described
or listed in this paragraph, if | 19 |
| that salt, ester, or isomer promotes muscle
growth.
| 20 |
| Any person who is otherwise lawfully in possession of an | 21 |
| anabolic
steroid, or who otherwise lawfully manufactures, | 22 |
| distributes, dispenses,
delivers, or possesses with intent to | 23 |
| deliver an anabolic steroid, which
anabolic steroid is | 24 |
| expressly intended for and lawfully allowed to be
administered | 25 |
| through implants to livestock or other nonhuman species, and
| 26 |
| which is approved by the Secretary of Health and Human Services |
|
|
|
09500HB0118sam001 |
- 9 - |
LRB095 03934 RAS 35945 a |
|
| 1 |
| for such
administration, and which the person intends to | 2 |
| administer or have
administered through such implants, shall | 3 |
| not be considered to be in
unauthorized possession or to | 4 |
| unlawfully manufacture, distribute, dispense,
deliver, or | 5 |
| possess with intent to deliver such anabolic steroid for
| 6 |
| purposes of this Act.
| 7 |
| (d) "Administration" means the Drug Enforcement | 8 |
| Administration,
United States Department of Justice, or its | 9 |
| successor agency.
| 10 |
| (e) "Control" means to add a drug or other substance, or | 11 |
| immediate
precursor, to a Schedule under Article II of this Act | 12 |
| whether by
transfer from another Schedule or otherwise.
| 13 |
| (f) "Controlled Substance" means a drug, substance, or | 14 |
| immediate
precursor in the Schedules of Article II of this Act.
| 15 |
| (g) "Counterfeit substance" means a controlled substance, | 16 |
| which, or
the container or labeling of which, without | 17 |
| authorization bears the
trademark, trade name, or other | 18 |
| identifying mark, imprint, number or
device, or any likeness | 19 |
| thereof, of a manufacturer, distributor, or
dispenser other | 20 |
| than the person who in fact manufactured, distributed,
or | 21 |
| dispensed the substance.
| 22 |
| (h) "Deliver" or "delivery" means the actual, constructive | 23 |
| or
attempted transfer of possession of a controlled substance, | 24 |
| with or
without consideration, whether or not there is an | 25 |
| agency relationship.
| 26 |
| (i) "Department" means the Illinois Department of Human |
|
|
|
09500HB0118sam001 |
- 10 - |
LRB095 03934 RAS 35945 a |
|
| 1 |
| Services (as
successor to the Department of Alcoholism and | 2 |
| Substance Abuse) or its successor agency.
| 3 |
| (j) "Department of State Police" means the Department of | 4 |
| State
Police of the State of Illinois or its successor agency.
| 5 |
| (k) "Department of Corrections" means the Department of | 6 |
| Corrections
of the State of Illinois or its successor agency.
| 7 |
| (l) "Department of Professional Regulation" means the | 8 |
| Department
of Professional Regulation of the State of Illinois | 9 |
| or its successor agency.
| 10 |
| (m) "Depressant" or "stimulant substance" means:
| 11 |
| (1) a drug which contains any quantity of (i) | 12 |
| barbituric acid or
any of the salts of barbituric acid | 13 |
| which has been designated as habit
forming under section | 14 |
| 502 (d) of the Federal Food, Drug, and Cosmetic
Act (21 | 15 |
| U.S.C. 352 (d)); or
| 16 |
| (2) a drug which contains any quantity of (i) | 17 |
| amphetamine or
methamphetamine and any of their optical | 18 |
| isomers; (ii) any salt of
amphetamine or methamphetamine or | 19 |
| any salt of an optical isomer of
amphetamine; or (iii) any | 20 |
| substance which the Department, after
investigation, has | 21 |
| found to be, and by rule designated as, habit forming
| 22 |
| because of its depressant or stimulant effect on the | 23 |
| central nervous
system; or
| 24 |
| (3) lysergic acid diethylamide; or
| 25 |
| (4) any drug which contains any quantity of a substance | 26 |
| which the
Department, after investigation, has found to |
|
|
|
09500HB0118sam001 |
- 11 - |
LRB095 03934 RAS 35945 a |
|
| 1 |
| have, and by rule
designated as having, a potential for | 2 |
| abuse because of its depressant or
stimulant effect on the | 3 |
| central nervous system or its hallucinogenic
effect.
| 4 |
| (n) (Blank).
| 5 |
| (o) "Director" means the Director of the Department of | 6 |
| State Police or
the Department of Professional Regulation or | 7 |
| his designated agents.
| 8 |
| (p) "Dispense" means to deliver a controlled substance to | 9 |
| an
ultimate user or research subject by or pursuant to the | 10 |
| lawful order of
a prescriber, including the prescribing, | 11 |
| administering, packaging,
labeling, or compounding necessary | 12 |
| to prepare the substance for that
delivery.
| 13 |
| (q) "Dispenser" means a practitioner who dispenses.
| 14 |
| (r) "Distribute" means to deliver, other than by | 15 |
| administering or
dispensing, a controlled substance.
| 16 |
| (s) "Distributor" means a person who distributes.
| 17 |
| (t) "Drug" means (1) substances recognized as drugs in the | 18 |
| official
United States Pharmacopoeia, Official Homeopathic | 19 |
| Pharmacopoeia of the
United States, or official National | 20 |
| Formulary, or any supplement to any
of them; (2) substances | 21 |
| intended for use in diagnosis, cure, mitigation,
treatment, or | 22 |
| prevention of disease in man or animals; (3) substances
(other | 23 |
| than food) intended to affect the structure of any function of
| 24 |
| the body of man or animals and (4) substances intended for use | 25 |
| as a
component of any article specified in clause (1), (2), or | 26 |
| (3) of this
subsection. It does not include devices or their |
|
|
|
09500HB0118sam001 |
- 12 - |
LRB095 03934 RAS 35945 a |
|
| 1 |
| components, parts, or
accessories.
| 2 |
| (t-5) "Euthanasia agency" means
an entity certified by the | 3 |
| Department of Professional Regulation for the
purpose of animal | 4 |
| euthanasia that holds an animal control facility license or
| 5 |
| animal
shelter license under the Animal Welfare Act. A | 6 |
| euthanasia agency is
authorized to purchase, store, possess, | 7 |
| and utilize Schedule II nonnarcotic and
Schedule III | 8 |
| nonnarcotic drugs for the sole purpose of animal euthanasia.
| 9 |
| (t-10) "Euthanasia drugs" means Schedule II or Schedule III | 10 |
| substances
(nonnarcotic controlled substances) that are used | 11 |
| by a euthanasia agency for
the purpose of animal euthanasia.
| 12 |
| (u) "Good faith" means the prescribing or dispensing of a | 13 |
| controlled
substance by a practitioner in the regular course of | 14 |
| professional
treatment to or for any person who is under his | 15 |
| treatment for a
pathology or condition other than that | 16 |
| individual's physical or
psychological dependence upon or | 17 |
| addiction to a controlled substance,
except as provided herein: | 18 |
| and application of the term to a pharmacist
shall mean the | 19 |
| dispensing of a controlled substance pursuant to the
| 20 |
| prescriber's order which in the professional judgment of the | 21 |
| pharmacist
is lawful. The pharmacist shall be guided by | 22 |
| accepted professional
standards including, but not limited to | 23 |
| the following, in making the
judgment:
| 24 |
| (1) lack of consistency of doctor-patient | 25 |
| relationship,
| 26 |
| (2) frequency of prescriptions for same drug by one |
|
|
|
09500HB0118sam001 |
- 13 - |
LRB095 03934 RAS 35945 a |
|
| 1 |
| prescriber for
large numbers of patients,
| 2 |
| (3) quantities beyond those normally prescribed,
| 3 |
| (4) unusual dosages,
| 4 |
| (5) unusual geographic distances between patient, | 5 |
| pharmacist and
prescriber,
| 6 |
| (6) consistent prescribing of habit-forming drugs.
| 7 |
| (u-1) "Home infusion services" means services provided by a | 8 |
| pharmacy in
compounding solutions for direct administration to | 9 |
| a patient in a private
residence, long-term care facility, or | 10 |
| hospice setting by means of parenteral,
intravenous, | 11 |
| intramuscular, subcutaneous, or intraspinal infusion.
| 12 |
| (v) "Immediate precursor" means a substance:
| 13 |
| (1) which the Department has found to be and by rule | 14 |
| designated as
being a principal compound used, or produced | 15 |
| primarily for use, in the
manufacture of a controlled | 16 |
| substance;
| 17 |
| (2) which is an immediate chemical intermediary used or | 18 |
| likely to
be used in the manufacture of such controlled | 19 |
| substance; and
| 20 |
| (3) the control of which is necessary to prevent, | 21 |
| curtail or limit
the manufacture of such controlled | 22 |
| substance.
| 23 |
| (w) "Instructional activities" means the acts of teaching, | 24 |
| educating
or instructing by practitioners using controlled | 25 |
| substances within
educational facilities approved by the State | 26 |
| Board of Education or
its successor agency.
|
|
|
|
09500HB0118sam001 |
- 14 - |
LRB095 03934 RAS 35945 a |
|
| 1 |
| (x) "Local authorities" means a duly organized State, | 2 |
| County or
Municipal peace unit or police force.
| 3 |
| (y) "Look-alike substance" means a substance, other than a | 4 |
| controlled
substance which (1) by overall dosage unit | 5 |
| appearance, including shape,
color, size, markings or lack | 6 |
| thereof, taste, consistency, or any other
identifying physical | 7 |
| characteristic of the substance, would lead a reasonable
person | 8 |
| to believe that the substance is a controlled substance, or (2) | 9 |
| is
expressly or impliedly represented to be a controlled | 10 |
| substance or is
distributed under circumstances which would | 11 |
| lead a reasonable person to
believe that the substance is a | 12 |
| controlled substance. For the purpose of
determining whether | 13 |
| the representations made or the circumstances of the
| 14 |
| distribution would lead a reasonable person to believe the | 15 |
| substance to be
a controlled substance under this clause (2) of | 16 |
| subsection (y), the court or
other authority may consider the | 17 |
| following factors in addition to any other
factor that may be | 18 |
| relevant:
| 19 |
| (a) statements made by the owner or person in control | 20 |
| of the substance
concerning its nature, use or effect;
| 21 |
| (b) statements made to the buyer or recipient that the | 22 |
| substance may
be resold for profit;
| 23 |
| (c) whether the substance is packaged in a manner | 24 |
| normally used for the
illegal distribution of controlled | 25 |
| substances;
| 26 |
| (d) whether the distribution or attempted distribution |
|
|
|
09500HB0118sam001 |
- 15 - |
LRB095 03934 RAS 35945 a |
|
| 1 |
| included an
exchange of or demand for money or other | 2 |
| property as consideration, and
whether the amount of the | 3 |
| consideration was substantially greater than the
| 4 |
| reasonable retail market value of the substance.
| 5 |
| Clause (1) of this subsection (y) shall not apply to a | 6 |
| noncontrolled
substance in its finished dosage form that was | 7 |
| initially introduced into
commerce prior to the initial | 8 |
| introduction into commerce of a controlled
substance in its | 9 |
| finished dosage form which it may substantially resemble.
| 10 |
| Nothing in this subsection (y) prohibits the dispensing or | 11 |
| distributing
of noncontrolled substances by persons authorized | 12 |
| to dispense and
distribute controlled substances under this | 13 |
| Act, provided that such action
would be deemed to be carried | 14 |
| out in good faith under subsection (u) if the
substances | 15 |
| involved were controlled substances.
| 16 |
| Nothing in this subsection (y) or in this Act prohibits the | 17 |
| manufacture,
preparation, propagation, compounding, | 18 |
| processing, packaging, advertising
or distribution of a drug or | 19 |
| drugs by any person registered pursuant to
Section 510 of the | 20 |
| Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
| 21 |
| (y-1) "Mail-order pharmacy" means a pharmacy that is | 22 |
| located in a state
of the United States, other than Illinois, | 23 |
| that delivers, dispenses or
distributes, through the United | 24 |
| States Postal Service or other common
carrier, to Illinois | 25 |
| residents, any substance which requires a prescription.
| 26 |
| (z) "Manufacture" means the production, preparation, |
|
|
|
09500HB0118sam001 |
- 16 - |
LRB095 03934 RAS 35945 a |
|
| 1 |
| propagation,
compounding, conversion or processing of a | 2 |
| controlled substance other than methamphetamine, either
| 3 |
| directly or indirectly, by extraction from substances of | 4 |
| natural origin,
or independently by means of chemical | 5 |
| synthesis, or by a combination of
extraction and chemical | 6 |
| synthesis, and includes any packaging or
repackaging of the | 7 |
| substance or labeling of its container, except that
this term | 8 |
| does not include:
| 9 |
| (1) by an ultimate user, the preparation or compounding | 10 |
| of a
controlled substance for his own use; or
| 11 |
| (2) by a practitioner, or his authorized agent under | 12 |
| his
supervision, the preparation, compounding, packaging, | 13 |
| or labeling of a
controlled substance:
| 14 |
| (a) as an incident to his administering or | 15 |
| dispensing of a
controlled substance in the course of | 16 |
| his professional practice; or
| 17 |
| (b) as an incident to lawful research, teaching or | 18 |
| chemical
analysis and not for sale.
| 19 |
| (z-1) (Blank).
| 20 |
| (aa) "Narcotic drug" means any of the following, whether | 21 |
| produced
directly or indirectly by extraction from substances | 22 |
| of natural origin,
or independently by means of chemical | 23 |
| synthesis, or by a combination of
extraction and chemical | 24 |
| synthesis:
| 25 |
| (1) opium and opiate, and any salt, compound, | 26 |
| derivative, or
preparation of opium or opiate;
|
|
|
|
09500HB0118sam001 |
- 17 - |
LRB095 03934 RAS 35945 a |
|
| 1 |
| (2) any salt, compound, isomer, derivative, or | 2 |
| preparation thereof
which is chemically equivalent or | 3 |
| identical with any of the substances
referred to in clause | 4 |
| (1), but not including the isoquinoline alkaloids
of opium;
| 5 |
| (3) opium poppy and poppy straw;
| 6 |
| (4) coca leaves and any salts, compound, isomer, salt | 7 |
| of an isomer,
derivative, or preparation of coca leaves | 8 |
| including cocaine or ecgonine,
and any salt, compound, | 9 |
| isomer, derivative, or preparation thereof which is
| 10 |
| chemically equivalent or identical with any of these | 11 |
| substances, but not
including decocainized coca leaves or | 12 |
| extractions of coca leaves which do
not contain cocaine or | 13 |
| ecgonine (for the purpose of this paragraph, the
term | 14 |
| "isomer" includes optical, positional and geometric | 15 |
| isomers).
| 16 |
| (bb) "Nurse" means a registered nurse licensed under the
| 17 |
| Nursing and Advanced Practice Nursing Act.
| 18 |
| (cc) (Blank).
| 19 |
| (dd) "Opiate" means any substance having an addiction | 20 |
| forming or
addiction sustaining liability similar to morphine | 21 |
| or being capable of
conversion into a drug having addiction | 22 |
| forming or addiction sustaining
liability.
| 23 |
| (ee) "Opium poppy" means the plant of the species Papaver
| 24 |
| somniferum L., except its seeds.
| 25 |
| (ff) "Parole and Pardon Board" means the Parole and Pardon | 26 |
| Board of
the State of Illinois or its successor agency.
|
|
|
|
09500HB0118sam001 |
- 18 - |
LRB095 03934 RAS 35945 a |
|
| 1 |
| (gg) "Person" means any individual, corporation, | 2 |
| mail-order pharmacy,
government or governmental subdivision or | 3 |
| agency, business trust, estate,
trust, partnership or | 4 |
| association, or any other entity.
| 5 |
| (hh) "Pharmacist" means any person who holds a certificate | 6 |
| of
registration as a registered pharmacist, a local registered | 7 |
| pharmacist
or a registered assistant pharmacist under the | 8 |
| Pharmacy Practice Act of 1987.
| 9 |
| (ii) "Pharmacy" means any store, ship or other place in | 10 |
| which
pharmacy is authorized to be practiced under the Pharmacy | 11 |
| Practice Act of 1987.
| 12 |
| (jj) "Poppy straw" means all parts, except the seeds, of | 13 |
| the opium
poppy, after mowing.
| 14 |
| (kk) "Practitioner" means a physician licensed to practice | 15 |
| medicine in all
its branches, dentist, podiatrist,
| 16 |
| veterinarian, scientific investigator, pharmacist, physician | 17 |
| assistant,
advanced practice nurse,
licensed practical
nurse, | 18 |
| registered nurse, hospital, laboratory, or pharmacy, or other
| 19 |
| person licensed, registered, or otherwise lawfully permitted | 20 |
| by the
United States or this State to distribute, dispense, | 21 |
| conduct research
with respect to, administer or use in teaching | 22 |
| or chemical analysis, a
controlled substance in the course of | 23 |
| professional practice or research.
| 24 |
| (ll) "Pre-printed prescription" means a written | 25 |
| prescription upon which
the designated drug has been indicated | 26 |
| prior to the time of issuance.
|
|
|
|
09500HB0118sam001 |
- 19 - |
LRB095 03934 RAS 35945 a |
|
| 1 |
| (mm) "Prescriber" means a physician licensed to practice | 2 |
| medicine in all
its branches, dentist, podiatrist or
| 3 |
| veterinarian who issues a prescription, a physician assistant | 4 |
| who
issues a
prescription for a Schedule III, IV, or V | 5 |
| controlled substance
in accordance
with Section 303.05 and the | 6 |
| written guidelines required under Section 7.5
of the
Physician | 7 |
| Assistant Practice Act of 1987, or an advanced practice
nurse | 8 |
| with prescriptive authority in accordance with Section 303.05
| 9 |
| and a written
collaborative agreement under Sections 15-15 and | 10 |
| 15-20 of
the Nursing and Advanced Practice Nursing Act , or an | 11 |
| underserved dental population licensee with prescriptive | 12 |
| authority in accordance with Section 11.5 of the Illinois | 13 |
| Dental Practice Act .
| 14 |
| (nn) "Prescription" means a lawful written, facsimile, or | 15 |
| verbal order
of
a physician licensed to practice medicine in | 16 |
| all its branches,
dentist, podiatrist or veterinarian for any | 17 |
| controlled
substance, of a physician assistant for a Schedule | 18 |
| III, IV, or V
controlled substance
in accordance with Section | 19 |
| 303.05 and the written guidelines required under
Section 7.5 of | 20 |
| the
Physician Assistant Practice Act of 1987, or of an advanced | 21 |
| practice
nurse who issues a prescription for a Schedule III, | 22 |
| IV, or V
controlled substance in accordance
with
Section 303.05 | 23 |
| and a written collaborative agreement under Sections 15-15
and
| 24 |
| 15-20 of the Nursing and Advanced Practice Nursing Act.
| 25 |
| (oo) "Production" or "produce" means manufacture, | 26 |
| planting,
cultivating, growing, or harvesting of a controlled |
|
|
|
09500HB0118sam001 |
- 20 - |
LRB095 03934 RAS 35945 a |
|
| 1 |
| substance other than methamphetamine.
| 2 |
| (pp) "Registrant" means every person who is required to | 3 |
| register
under Section 302 of this Act.
| 4 |
| (qq) "Registry number" means the number assigned to each | 5 |
| person
authorized to handle controlled substances under the | 6 |
| laws of the United
States and of this State.
| 7 |
| (rr) "State" includes the State of Illinois and any state, | 8 |
| district,
commonwealth, territory, insular possession thereof, | 9 |
| and any area
subject to the legal authority of the United | 10 |
| States of America.
| 11 |
| (ss) "Ultimate user" means a person who lawfully possesses | 12 |
| a
controlled substance for his own use or for the use of a | 13 |
| member of his
household or for administering to an animal owned | 14 |
| by him or by a member
of his household.
| 15 |
| (Source: P.A. 93-596, eff. 8-26-03; 93-626, eff. 12-23-03; | 16 |
| 94-556, eff. 9-11-05.)
| 17 |
| Section 99. Effective date. This Act takes effect upon | 18 |
| becoming law.".
|
|